These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 28832682)
1. Ancestry as a potential modifier of gene expression in breast tumors from Colombian women. Serrano-Gómez SJ; Sanabria-Salas MC; Garay J; Baddoo MC; Hernández-Suarez G; Mejía JC; García O; Miele L; Fejerman L; Zabaleta J PLoS One; 2017; 12(8):e0183179. PubMed ID: 28832682 [TBL] [Abstract][Full Text] [Related]
2. Association of genetic ancestry with HER2, GRB7 AND estrogen receptor expression among Colombian women with breast cancer. Rey-Vargas L; Bejarano-Rivera LM; Mejia-Henao JC; Sua LF; Bastidas-Andrade JF; Ossa CA; Gutiérrez-Castañeda LD; Fejerman L; Sanabria-Salas MC; Serrano-Gómez SJ Front Oncol; 2022; 12():989761. PubMed ID: 36620598 [TBL] [Abstract][Full Text] [Related]
3. Interaction between genetic ancestry and common breast cancer susceptibility variants in Colombian women. Torres D; Lorenzo Bermejo J; Garcia Mesa K; Gilbert M; Briceño I; Pohl-Zeidler S; González Silos R; Boekstegers F; Plass C; Hamann U Int J Cancer; 2019 May; 144(9):2181-2191. PubMed ID: 30485434 [TBL] [Abstract][Full Text] [Related]
4. Genetic ancestry and risk of mortality among U.S. Latinas with breast cancer. Fejerman L; Hu D; Huntsman S; John EM; Stern MC; Haiman CA; Pérez-Stable EJ; Ziv E Cancer Res; 2013 Dec; 73(24):7243-53. PubMed ID: 24177181 [TBL] [Abstract][Full Text] [Related]
5. Genetic ancestry is related to potential sources of breast cancer health disparities among Colombian women. Rey-Vargas L; Bejarano-Rivera LM; Serrano-Gómez SJ PLoS One; 2024; 19(6):e0306037. PubMed ID: 38935662 [TBL] [Abstract][Full Text] [Related]
6. Genetic ancestry and risk of breast cancer among U.S. Latinas. Fejerman L; John EM; Huntsman S; Beckman K; Choudhry S; Perez-Stable E; Burchard EG; Ziv E Cancer Res; 2008 Dec; 68(23):9723-8. PubMed ID: 19047150 [TBL] [Abstract][Full Text] [Related]
7. Native American ancestry and breast cancer risk in Colombian and Mexican women: ruling out potential confounding through ancestry-informative markers. Zollner L; Torres D; Briceno I; Gilbert M; Torres-Mejía G; Dennis J; Bolla MK; Wang Q; Hamann U; Lorenzo Bermejo J Breast Cancer Res; 2023 Oct; 25(1):111. PubMed ID: 37784177 [TBL] [Abstract][Full Text] [Related]
8. Genetic Ancestry Is not Associated with Breast Cancer Recurrence or Survival in U.S. Latina Women Enrolled in the Kaiser Permanente Pathways Study. Engmann NJ; Ergas IJ; Yao S; Kwan ML; Roh JM; Ambrosone CB; Kushi LH; Fejerman L Cancer Epidemiol Biomarkers Prev; 2017 Sep; 26(9):1466-1469. PubMed ID: 28864455 [No Abstract] [Full Text] [Related]
9. Genetic Ancestry-specific Molecular and Survival Differences in Admixed Patients With Breast Cancer. Telonis AG; Rodriguez DA; Spanheimer PM; Figueroa ME; Goel N Ann Surg; 2024 May; 279(5):866-873. PubMed ID: 38073557 [TBL] [Abstract][Full Text] [Related]
10. Genetic ancestry and radical prostatectomy findings in Hispanic/Latino patients. Acosta-Vega NL; Varela R; Mesa JA; Garai J; Gómez-Gutiérrez A; Serrano-Gómez SJ; Zabaleta J; Sanabria-Salas MC; Combita AL Front Oncol; 2024; 14():1338250. PubMed ID: 38634046 [TBL] [Abstract][Full Text] [Related]
11. Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer. Cejalvo JM; Martínez de Dueñas E; Galván P; García-Recio S; Burgués Gasión O; Paré L; Antolín S; Martinello R; Blancas I; Adamo B; Guerrero-Zotano Á; Muñoz M; Nucíforo P; Vidal M; Pérez RM; Chacón López-Muniz JI; Caballero R; Peg V; Carrasco E; Rojo F; Perou CM; Cortés J; Adamo V; Albanell J; Gomis RR; Lluch A; Prat A Cancer Res; 2017 May; 77(9):2213-2221. PubMed ID: 28249905 [TBL] [Abstract][Full Text] [Related]
12. An ancestry informative marker panel design for individual ancestry estimation of Hispanic population using whole exome sequencing data. Wang LJ; Zhang CW; Su SC; Chen HH; Chiu YC; Lai Z; Bouamar H; Ramirez AG; Cigarroa FG; Sun LZ; Chen Y BMC Genomics; 2019 Dec; 20(Suppl 12):1007. PubMed ID: 31888480 [TBL] [Abstract][Full Text] [Related]
13. Breast cancer molecular class ERBB2: preponderance of tumors with apocrine differentiation and expression of basal phenotype markers CK5, CK5/6, and EGFR. Bhargava R; Beriwal S; Striebel JM; Dabbs DJ Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):113-8. PubMed ID: 19801938 [TBL] [Abstract][Full Text] [Related]
14. Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups. Netanely D; Avraham A; Ben-Baruch A; Evron E; Shamir R Breast Cancer Res; 2016 Jul; 18(1):74. PubMed ID: 27386846 [TBL] [Abstract][Full Text] [Related]
15. Genetic Ancestry of 1127 Brazilian Breast Cancer Patients and Its Correlation With Molecular Subtype and Geographic Region. da Costa Vieira RA; Sant'Anna D; Laus AC; Bacchi CE; Silva RJC; de Oliveira-Junior I; da Silva VD; Pereira R; Reis RM Clin Breast Cancer; 2023 Jul; 23(5):527-537. PubMed ID: 37183096 [TBL] [Abstract][Full Text] [Related]
16. Genetic variation in genes involved in hormones, inflammation and energetic factors and breast cancer risk in an admixed population. Slattery ML; John EM; Torres-Mejia G; Lundgreen A; Herrick JS; Baumgartner KB; Hines LM; Stern MC; Wolff RK Carcinogenesis; 2012 Aug; 33(8):1512-21. PubMed ID: 22562547 [TBL] [Abstract][Full Text] [Related]
17. Radiogenomic Analysis of Breast Cancer by Using B-Mode and Vascular US and RNA Sequencing. Park AY; Han MR; Park KH; Kim JS; Son GS; Lee HY; Chang YW; Park EK; Cha SH; Cho Y; Hong H; Cho KR; Song SE; Woo OH; Lee JH; Cha J; Seo BK Radiology; 2020 Apr; 295(1):24-34. PubMed ID: 32013793 [TBL] [Abstract][Full Text] [Related]